Document Mentions (4 shared documents)

EFTA00136746

2 mentions1 same-page

Page ?Same page

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

er <https://www.washingtonexaminer.com/news/mueller-prosecutor-andrew- weissmann-says-he-would-be-happy-to-share-information-with-john-durham> (9/30, Chaitin, 448K) reports Weissman added, "I don't think, given what I understand he's looking at, which is the genesis of the Russia investigation, which I w

EFTA00135712

2 mentions1 same-page

Page ?Same page

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

a investigation, which I was involved in, I don't suspect that I'm going to have particularly relevant information." The Washington Fxaminer (9/30, Chaitin, 448K) reports Weissman added, "I don't think, given what I understand he's looking at, which is the genesis of the Russia investigation, which I w

EFTA00148896

2 mentions1 same-page

Page ?Same page

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

a investigation, which I was involved in, I don't suspect that I'm going to have particularly relevant information." The Washington Examiner (9/30, Chaitin, 448K) reports Weissman added, "I don't think, given what I understand he's looking at, which is the genesis of the Russia investigation, which I w